Belgium· BE-AMP-SAM521137-00

Atremia 0.5 mg

A anagrelide product containing anagrelide hydrochloride monohydrate, registered in Belgium by Teva. The same ATC class is registered in 19 of our 19 countries.

ATC L01XX35

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about anagrelide hydrochloride monohydrateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Anagrelide is registered in 19 of 19 countries.

Countries holding a registration under ATC L01XX35 (anagrelide), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
11 of them publish a price we can compare per daily dose

Search anagrelide products by name

Anagrelide · ATC L01XX35

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of anagrelide costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Anagrelide · price per daily dose (2 mg)

USD · FX 28 Sept 2026

IT Italy$15.54
ES Spain$14.25
CH Switzerland$11.36

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Anagrelide Hydrochloride Monohydrate
Manufacturer: Teva
Country: Belgium (BE)
ATC code: L01XX35
ATC class: Anagrelide
Defined daily dose: 2 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
7722085
be_apb
3699386

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

438 interactions on record for anagrelide.

Graded by severity as the source publishes them — 274 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check anagrelide against other medicines How interaction checks work

Anagrelide · interactions on record

438 records

274 severe
156 moderate
4 minor
4 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Anagrelide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All anagrelide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Anagrelid +pharma, Anagrelid Aop
Bulgaria · Тромборедуктин
Cyprus · Anagrelide Aop
Czechia · Anagrelid Stada, Anagrelide Teva
Germany · Anagrelid Abz, Anagrelid Al
Denmark · Anagrelid Bluefish, Anagrelide "stada"
Spain · Anagrelida Aurovitas, Anagrelida Bluefish
Finland · Anagrelid Avansor, Anagrelid Orion
France · Anagrelide Arrow, Anagrelide Biogaran
United Kingdom (Northern Ireland) · Anagrelide Bluefish, Anagrelide Brown & Burk Uk
Greece · Anagrelide Aop, Anagrelide Teva
Croatia · Anagrelid, Anagrelid Stada
Hungary · Adride, Anagrelide Stada
Ireland · Anagrelide Athlone Pharmaceuticals
Iceland · Anagrelide Bluefish, Anagrelide Viatris
Italy · Anagrelide Aurobindo, Anagrelide Sandoz
Liechtenstein · Anagrelide Viatris, Xagrid
Lithuania · Anagrelide Teva, Thromboreductin
Luxembourg · Atremia
Latvia · Thromboreductin
Malta · Anagrelide Torrent
Netherlands · Anagrelide Accord, Anagrelide Cf
Norway · Anagrelide Bluefish, Anagrelide Viatris
Poland · Anagrelid Aurovitas, Anagrelide
Portugal · Anagrelida Aurovitas, Anagrelida Bluefish
Romania · Anagrelidă Accord, Grenalvon
Sweden · Anagrelid Accordpharma, Anagrelid Avansor
Slovenia · Anagrelid Sandoz, Anagrelid Teva
Slovakia · Anagrelide Glenmark, Anagrelide Vipharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/103165b4-9837-44d2-813d-c0cf3d94ad7d
GET /v1/drugs/103165b4-9837-44d2-813d-c0cf3d94ad7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Atremia 0.5 mg",
  "name_fr": "Atremia 0.5 mg",
  "name_nl": "Atremia 0.5 mg",
  "amp_code": "SAM521137-00",
  "strengths": [
    "0.6100",
    "0.5000",
    "32.9000",
    "28.0300"
  ],
  "pack_count": 2,
  "substances": [
    "Anagrelide Hydrochloride Monohydrate",
    "Anagrelide",
    "Lactose",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Anagrelide",
  "authorisation_numbers": [
    "BE521137"
  ]
}

API reference MCP server Plans

See everything about anagrelide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console